Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03157128
Title	A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) (LIBRETTO-001)
Acronym	LIBRETTO-001
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Loxo Oncology, Inc.
Indications	thyroid cancer medullary thyroid carcinoma lung non-small cell carcinoma pheochromocytoma Advanced Solid Tumor
Therapies	Selpercatinib
Age Groups:	adult \| child \| senior
Covered Countries	USA \| ITA \| ISR \| GBR \| FRA \| ESP \| DNK \| DEU \| CHE \| CAN \| AUS